arrow
K

Kyriaki Papadopoulou

hellenic foundation for cancer research
H指数:16
被引数:761

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Molecular, Clinicopathological and Immune Profiling of Non-Small Cell Lung Cancer: The MONREPOS Hellenic Cooperative Oncology Group (HeCOG) Study (HE_2TR/13)

非小细胞肺癌的整合分子、临床病理和免疫特征分析:MONREPOS 希腊合作肿瘤学组 (HeCOG) 研究 (HE_2TR/13)

2026-09-300
OA
Understanding Exceptional Response: The Role of MINDY1 SNP in CDK4/6 Inhibitor Therapy for ER-Positive, HER2-Negative Advanced Breast Cancer

理解超常反应:MINDY1 SNP在ER阳性、HER2阴性晚期乳腺癌CDK4/6抑制剂疗法中的作用

2025-12-240
OAAI
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.

插入式阿维鲁唑胺联合铂类为基础的化疗在广泛期小细胞肺癌患者中的应用(PAVE):一项多中心Hellenic Cooperative Oncology Group II期研究的最终结果、免疫表型分析和生物标志物分析。

2025-07-250
OAAI
Management of patients with pleural infection in Greece: initial results of the ongoing PRACTICE (PleuRAl InfeCTIon in GreeCE) study
2024-10-300
PRE
Analysis of evolution of patient reported side effects during treatment for advanced NSCLC

对晚期非小细胞肺癌治疗期间患者报告的不良反应演变分析

2024-09-010
PRE
The Mutographs biorepository: A unique genomic resource to study cancer around the world
2024-03-012
OAAI
Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis

晚期非小细胞肺癌患者数字支持的临床和分子研究: snf-climedin,一项前瞻性随机希腊肿瘤协作组 (HeCOG) 研究: 中期分析

2023-10-011
OAAI
Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

接受预防性手术的BRCA1/2携带者的组织基因组学随访

2021-07-240
PREAI
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

上皮性卵巢癌患者的肿瘤基因分型和同源重组修复基因变异: 致病性足够吗?

2021-06-011
OAAI
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab

血管生成和抗血管生成VEGFA剪接变异体在结直肠癌中的应用: 基于伊立替康化疗和贝伐单抗的前瞻性回顾性队列研究

2019-12-0120
PREAI
Prognostic impact of SRC, CDKN1B and JAK2 expression in metastatic breast cancer patients treated with trastuzumab

SRC、CDKN1B和JAK2表达对曲妥珠单抗治疗转移性乳腺癌患者预后的影响

2019-02-150
PRE
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)

在接受基于nab-紫杉醇的化疗或靶向EGFR轴的药物治疗的患者队列中,通过靶向下一代测序对胰腺癌进行基因定位: 希腊肿瘤协作组 (HeCOG) 的回顾性分析

2019-01-016
OAAI
Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab

曲妥珠单抗治疗晚期乳腺癌患者的细胞周期蛋白D1差异激活及其对预后的影响

2019-01-014
OAAI
Somatic involution of pathogenic BRCA1 germline mutations

致病性BRCA1种系突变的体细胞退化

2018-07-010
PRE
Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe

普遍存在的体细胞BRCA1突变形成了东南欧鼻咽癌的临床相关基因组模式

2017-09-3016
OAAI
The fate of germline BRCA related mutations in breast tumor tissues

乳腺肿瘤组织中生殖系BRCA相关突变的命运

2017-07-010
PRE